title: Severe thrombocytopenia and fibrinolysis mimicking disseminated intravascular coagulation after rituximab infusion.
authors.forename: Ioannis
authors.initials: I
authors.lastname: Kotsianidis
authors.forename: Aggelos
authors.initials: A
authors.lastname: Goutzouvelidis
authors.forename: Athanasios
authors.initials: A
authors.lastname: Anastasiades
authors.forename: Irene
authors.initials: I
authors.lastname: Bouchliou
authors.forename: Evangelia
authors.initials: E
authors.lastname: Nakou
authors.forename: Emmanouil
authors.initials: E
authors.lastname: Spanoudakis
authors.forename: Anna V
authors.initials: AV
authors.lastname: Christophoridou
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Margaritis
authors.forename: George
authors.initials: G
authors.lastname: Bourikas
authors.forename: Costas
authors.initials: C
authors.lastname: Tsatalas
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004211:Disseminated Intravascular Coagulation / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008218:Lymphocytosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D000069283:Rituximab; D012720:Severity of Illness Index; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy; D013997:Time Factors
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab